Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
The journal of nutrition, health & aging
Metadata
Title
Hypovitaminosis D in the elderly: From bone to brain
Authors
E. P. Cherniack
H. Florez
B. A. Roos
B. R. Troen
S. Levis
Publication date
01-07-2008
Publisher
Springer-Verlag
Published in
The journal of nutrition, health & aging / Issue 6/2008
Print ISSN: 1279-7707
Electronic ISSN: 1760-4788
DOI
https://doi.org/10.1007/BF02982668

Other articles of this Issue 6/2008

The journal of nutrition, health & aging 6/2008 Go to the issue

OriginalPaper

Dietary fatty acids, age-related cognitive decline, and mild cognitive impairment

OriginalPaper

Nutrition and aging. The Carla workshop

OriginalPaper

A randomized controlled trial on early physiotherapy intervention versus usual care in acute car unit for elderly: Potential benefits in light of dietary intakes

OriginalPaper

Forced mild physical training-induced effects on cognitive and locomotory behavior in old mice

OriginalPaper

Exercise interventions for dementia and cognitive impairment: The Seattle Protocols

OriginalPaper

Endurance and strength training outcomes on cognitively impaired and cognitively intact older adults: A meta-analysis

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits